EUVIMEDEUVIMED entdecken
MetaanalyseSystematische Übersicht

Effect of Bile Acid Sequestrants on the Risk of Cardiovascular Events

Stephanie Ross, Matthew D'Mello, Sonia S Anand, John Eikelboom, CARDIoGRAMplusC4D Consortium, Alexandre F R Stewart, Nilesh J Samani, Robert Roberts, Guillaume Paré

Circulation: Cardiovascular Genetics · 2015-08 · 8 (4) · 618-627

DOI: 10.1161/circgenetics.114.000952 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Circulation: Cardiovascular Genetics, 2015-08. Verfasst von Stephanie Ross und 8 weiteren Autor:innen. Beteiligte Einrichtung: From the Population Health Research Institute, Hamilton Health Sciences (S.R., M.D'M., S.S.A., J.E., G.P.), Department of Clinical Epidemiology & Bio…. Die Arbeit wurde bisher 85-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background— Statins lower low-density lipoprotein cholesterol (LDL-C) and risk of coronary artery disease (CAD), but they may be ineffective or not tolerated. Bile acid sequestrants (BAS) reduce LDL-C, yet their clinical efficacy on CAD remains controversial. Methods and Results— We conducted a systematic review and meta-analysis of randomized controlled trials to assess the effect of cholestyramine and colesevelam. We then used Mendelian randomization to estimate the effect of BAS on reducing the risk of CAD. First, we quantified the effect of rs4299376 ( ABCG5/ABCG8 ), which affects the intestinal cholesterol absorption pathway targeted by BAS and then we used these estimates to predict the effect of BAS on CAD. Nineteen randomized controlled trials with a total of 7021 study participants were included. Cholestyramine 24 g/d was associated with a reduction in LDL-C of 23.5 mg/dL (95% confidence interval [CI] −26.8,−20.2; N=3806) and a trend toward reduced risk of CAD (odds ratio 0.81, 95% CI 0.70–1.02; P =0.07; N=3806), whereas colesevelam 3.75 g/d was associated with a reduction in LDL-C of 22.7 mg/dL (95% CI −28.3, −17.2; N=759). Based on the findings that rs4299376 was associated with a 2.75 mg/dL decrease in LDL-C and a 5% decrease in risk of CAD outcomes, we estimated that cholestyramine was associated with an odds ratio for CAD of 0.63 (95% CI 0.52–0.77; P =6.3×10 −6 ) and colesevelam with an odds ratio of 0.64 (95% CI 0.52–0.79, P =4.3×10 −5 ), which were not statistically different from BAS clinical trials ( P >0.05). Conclusions— The cholesterol lowering effect of BAS may translate into a clinically relevant reduction in CAD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ATP Binding Cassette Transporter, Subfamily G, Member 5ATP Binding Cassette Transporter, Subfamily G, Member 8ATP-Binding Cassette TransportersAnticholesteremic AgentsBile Acids and SaltsCholesterol, LDLCholestyramine ResinColesevelam HydrochlorideCoronary Artery DiseaseHumansLipoproteinsMendelian Randomization AnalysisPolymorphism, Single NucleotideRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

Mendelian randomizationcholesterol-lowering drugscoronary artery diseasegeneticslipids

Substanzen

ABCG5 protein, humanABCG8 protein, humanATP Binding Cassette Transporter, Subfamily G, Member 5ATP Binding Cassette Transporter, Subfamily G, Member 8ATP-Binding Cassette TransportersAnticholesteremic AgentsBile Acids and SaltsCholesterol, LDLLipoproteinsCholestyramine Resin

Autor:innen und Institutionen

  • From the Population Health Research Institute, Hamilton Health Sciences (S.R., M.D'M., S.S.A., J.E., G.P.), Department of Clinical Epidemiology & Biostatistics, Population Genomics Program (S.R., M.D'M., S.S.A., G.P.),…

Förderung

  • Canadian Institutes of Health Research

Zitieren

APA

Ross, S., D'Mello, M., Anand, S. S., Eikelboom, J., CARDIoGRAMplusC4D Consortium, Stewart, A. F., Samani, N. J., Roberts, R., & Paré, G. (2015). Effect of Bile Acid Sequestrants on the Risk of Cardiovascular Events. Circulation: Cardiovascular Genetics, 8(4), 618-627. https://doi.org/10.1161/circgenetics.114.000952

Vancouver

Ross S, D'Mello M, Anand SS, Eikelboom J, CARDIoGRAMplusC4D Consortium, Stewart AF, et al. Effect of Bile Acid Sequestrants on the Risk of Cardiovascular Events. Circulation: Cardiovascular Genetics. 2015;8(4):618-627. doi:10.1161/circgenetics.114.000952

BibTeX
@article{Ross2015,
  author = {Ross, Stephanie and D'Mello, Matthew and Anand, Sonia S and Eikelboom, John and CARDIoGRAMplusC4D Consortium, CARDIoGRAMplusC4D Consortium and Stewart, Alexandre F R and Samani, Nilesh J and Roberts, Robert and Paré, Guillaume},
  title = {Effect of Bile Acid Sequestrants on the Risk of Cardiovascular Events},
  journal = {Circulation: Cardiovascular Genetics},
  year = {2015},
  volume = {8},
  number = {4},
  pages = {618--627},
  doi = {10.1161/circgenetics.114.000952}
}
Kostenlos starten →